Starr Surgical reported a net income of $1.8 million, or $0.04 per share, in the second quarter of 2018 compared with a net loss of $1 million, or $0.02 per share, in 2017’s second quarter.
Net sales grew 55% from $21.9 million in last year’s second quarter to $33.9 million this year, which was driven by ICL revenue and unit growth, according to a press release.
General and administrative expenses went up from $4.7 million to $6.2 million, research and development expenses increased from $4.8 million to $5.3 million, and (Read more...)
Uncategorized